Berger MS - Search Results

1

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.

Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B. Spence AM, et al. Among authors: berger ms. J Neurooncol. 1992 Feb;12(2):187-91. doi: 10.1007/BF00172671. J Neurooncol. 1992. PMID: 1560266 Clinical Trial.

2

Reoperation for glioma.

Berger MS, Tucker A, Spence A, Winn HR. Berger MS, et al. Clin Neurosurg. 1992;39:172-86. Clin Neurosurg. 1992. PMID: 1333931 Review. No abstract available.

3

Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies.

Le Roux PD, Berger MS, Wang K, Mack LA, Ojemann GA. Le Roux PD, et al. Among authors: berger ms. J Neurooncol. 1992 Jun;13(2):189-98. doi: 10.1007/BF00172770. J Neurooncol. 1992. PMID: 1432034

4

Differentiation of a primitive neuroectodermal tumor into a benign ganglioglioma.

Geyer JR, Schofield D, Berger M, Milstein J. Geyer JR, et al. J Neurooncol. 1992 Nov;14(3):237-41. doi: 10.1007/BF00172599. J Neurooncol. 1992. PMID: 1460486

5

The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma.

Bourne JP, Geyer R, Berger M, Griffin B, Milstein J. Bourne JP, et al. J Neurooncol. 1992 Nov;14(3):263-70. doi: 10.1007/BF00172602. J Neurooncol. 1992. PMID: 1460489

6

Infants with medulloblastoma: a single institution review of survival.

Geyer R, Levy M, Berger MS, Milstein J, Griffin B, Bleyer WA. Geyer R, et al. Among authors: berger ms. Neurosurgery. 1991 Nov;29(5):707-10; discussion 710-1. Neurosurgery. 1991. PMID: 1961400

7

DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.

Ali-Osman F, Srivenugopal K, Berger MS, Stein DE. Ali-Osman F, et al. Among authors: berger ms. Anticancer Res. 1990 May-Jun;10(3):677-82. Anticancer Res. 1990. PMID: 2164350

8

Use of quinones in brain-tumor therapy: preliminary results of preclinical laboratory investigations.

Berger MS, Talcott RE, Rosenblum ML, Silva M, AliOsman F, Smith MT. Berger MS, et al. J Toxicol Environ Health. 1985;16(5):713-9. doi: 10.1080/15287398509530781. J Toxicol Environ Health. 1985. PMID: 2419579

9

Favorable prognosis for brainstem gliomas in neurofibromatosis.

Milstein JM, Geyer JR, Berger MS, Bleyer WA. Milstein JM, et al. Among authors: berger ms. J Neurooncol. 1989 Nov;7(4):367-71. doi: 10.1007/BF02147094. J Neurooncol. 1989. PMID: 2511279

10

Neutron radiotherapy for malignant gliomas.

Griffin BR, Berger MS, Laramore GE, Griffin TW, Shuman WP, Parker RG, Davis LW, Diener-West M. Griffin BR, et al. Among authors: berger ms. Am J Clin Oncol. 1989 Aug;12(4):311-5. doi: 10.1097/00000421-198908000-00007. Am J Clin Oncol. 1989. PMID: 2547303 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

842 results

Search Page

Filters